Gilead Virus Treatment Is Promising But No Silver Bullet Yet

Gilead Virus Treatment Is Promising But No Silver Bullet Yet

Sam Fazeli, Director of Research: EMEA for Bloomberg Intelligence, on Gilead's positive trial for a potential coronavirus treatment. Lisa Shalett, Chief Investment Officer: Wealth Management for Morgan Stanley, discusses why she wants clients to avoid S&P indices and to actively manage stock picks. David Garrity, Chief Market Strategist for Laidlaw & Co, and Partner at BTblock, discusses Google, Facebook and Big Tech earnings. Brooke Sutherland, Bloomberg Opinion Industrials columnist, on the stark reality for Boeing.

See omnystudio.com/listener for privacy information.

Episoder(3351)

Drug Prices Increased 35 to 435%, Despite Trump Pledge

Drug Prices Increased 35 to 435%, Despite Trump Pledge

Michael Rea, Founder and CEO of RX Savings Solutions, discusses how drug companies are ignoring Trump and raising prices, and the increase in spread pricing from PBMs. Hosted by Pimm Fox and Lisa Abra...

12 Sep 201827min

CalSTR's Ailman: Market Shifting To Private Companies

CalSTR's Ailman: Market Shifting To Private Companies

Chris Ailman, Chief Investment Officer for CalSTRS, on his investment strategy, trade wars, and hedging the portfolio. Jim Anderson, CEO of SocialFlow, on creating a new blockchain-enabled digital adv...

11 Sep 201838min

Argentina Has ’Passed The EM Test’ While Turkey Fails

Argentina Has ’Passed The EM Test’ While Turkey Fails

Eric Fine, Portfolio Manager:Emerging Markets Fixed Income Strategy for Van Eck Global, on emerging market strategy, and why he still likes Argentina. Porter Bibb, Managing Partner for MediaTech Capit...

10 Sep 201828min

See Tesla At $88 By End of 2019: Vertical's Johnson

See Tesla At $88 By End of 2019: Vertical's Johnson

Gordon Johnson, Analyst and Managing Director at Vertical Group, on Tesla shares tanking after two top executives announced their departures, a day after CEO Elon Musk smoked a joint during an intervi...

7 Sep 201826min

We Have All The Elements Of EM Contagion: Bill Rhodes

We Have All The Elements Of EM Contagion: Bill Rhodes

"Banker to the World" Bill Rhodes, President and CEO of William Rhodes Global Advisor on the emerging markets meltdown, Argentina, and trade negotiations. Bloomberg Opinion columnist Al Hunt discusses...

6 Sep 201828min

Former Apple Engineer Unveils Jobs' Creative Process

Former Apple Engineer Unveils Jobs' Creative Process

Ken Kocienda, former Principal Engineer of iPhone software at Apple, discusses his new book, "Creative Selection: Inside Apple’s Design Process During the Golden Age of Steve Jobs." Mark Douglas, CEO ...

6 Sep 201827min

Expect Kavanaugh To Deflect With 'Settled Law' Jargon

Expect Kavanaugh To Deflect With 'Settled Law' Jargon

June Grasso, legal analyst and Bloomberg Law host, on what to expect from the Brett Kavanaugh Senate hearings. Burt Flickinger, Managing Director for Strategic Resource Group, on Nike's new ad campaig...

4 Sep 201827min

New China Tariffs Would Quickly Hurt Economy: Hufbauer

New China Tariffs Would Quickly Hurt Economy: Hufbauer

Gary Hufbauer, nonresident senior fellow at the Peterson Institute, on Trump's NAFTA renegotiation and how the Mexico agreement compares, and what Trump's goal is with trade for the US. Tad Rivelle, C...

4 Sep 201828min

Populært innen Business og økonomi

stopp-verden
lydartikler-fra-aftenposten
dine-penger-pengeradet
e24-podden
rss-borsmorgen-okonominyhetene
rss-penger-polser-og-politikk
finansredaksjonen
pengepodden-2
rss-sunn-okonomi
morgenkaffen-med-finansavisen
utbytte
livet-pa-veien-med-jan-erik-larssen
tid-er-penger-en-podcast-med-peter-warren
pengesnakk
okonomiamatorene
liberal-halvtime
lederpodden
stormkast-med-valebrokk-stordalen
rss-markedspuls-2
arcticpodden